HK1211019A1 - Benzyl sulfonamide derivatives as rorc modulators rorc - Google Patents

Benzyl sulfonamide derivatives as rorc modulators rorc

Info

Publication number
HK1211019A1
HK1211019A1 HK15111850.9A HK15111850A HK1211019A1 HK 1211019 A1 HK1211019 A1 HK 1211019A1 HK 15111850 A HK15111850 A HK 15111850A HK 1211019 A1 HK1211019 A1 HK 1211019A1
Authority
HK
Hong Kong
Prior art keywords
rorc
modulators
sulfonamide derivatives
benzyl sulfonamide
benzyl
Prior art date
Application number
HK15111850.9A
Other languages
English (en)
Chinese (zh)
Inventor
Van Niel Monique Bodil
Benjamin Fauber
Olivier Rene
Stuart Ward
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1211019A1 publication Critical patent/HK1211019A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epidemiology (AREA)
HK15111850.9A 2012-12-10 2015-12-02 Benzyl sulfonamide derivatives as rorc modulators rorc HK1211019A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261735364P 2012-12-10 2012-12-10
PCT/EP2013/075876 WO2014090710A1 (en) 2012-12-10 2013-12-09 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS

Publications (1)

Publication Number Publication Date
HK1211019A1 true HK1211019A1 (en) 2016-05-13

Family

ID=49753168

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15111850.9A HK1211019A1 (en) 2012-12-10 2015-12-02 Benzyl sulfonamide derivatives as rorc modulators rorc
HK19101448.5A HK1258966A1 (zh) 2012-12-10 2019-01-28 作為rorc調節劑的苄基磺酰胺衍生物

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK19101448.5A HK1258966A1 (zh) 2012-12-10 2019-01-28 作為rorc調節劑的苄基磺酰胺衍生物

Country Status (11)

Country Link
US (1) US9302985B2 (pt)
EP (1) EP2928863A1 (pt)
JP (1) JP6367823B2 (pt)
KR (1) KR20150092162A (pt)
CN (2) CN108409613A (pt)
BR (1) BR112015007862A2 (pt)
CA (1) CA2886471A1 (pt)
HK (2) HK1211019A1 (pt)
MX (1) MX2015006844A (pt)
RU (1) RU2015124564A (pt)
WO (1) WO2014090710A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016008721A (es) * 2014-01-10 2017-01-26 Hoffmann La Roche Derivados de aril sultama como moduladores del receptor huerfano relacionado con acido retinoico (rorc).
CN104892470B (zh) * 2015-06-11 2017-04-12 嘉兴学院 制备n‑烷基对甲苯磺酰胺的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005090297A1 (en) * 2004-03-19 2005-09-29 Biotie Therapies Corporation Sulphonamide derivatives
BRPI0513864A (pt) * 2004-07-28 2008-05-20 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades
PE20080906A1 (es) * 2006-08-17 2008-07-05 Kemia Inc Derivados heteroarilo como inhibidores de citocina
WO2008042867A2 (en) * 2006-09-29 2008-04-10 Emiliem Inc. Modulators of multiple kinases
WO2008075353A1 (en) * 2006-12-19 2008-06-26 Pharmos Corporation Sulfonamide derivatives with therapeutic indications
GB0705400D0 (en) * 2007-03-21 2007-05-02 Univ Aberdeen Therapeutic compounds andm their use
US8039493B2 (en) * 2007-09-27 2011-10-18 Hoffmann-La Roche Inc. Biaryl sulfonamide derivatives
US20100311736A1 (en) * 2007-10-22 2010-12-09 Glaxosmithkline Llc Pyridosulfonamide derivatives as p13 kinase inhibitors
US20100197688A1 (en) * 2008-05-29 2010-08-05 Nantermet Philippe G Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
GB0817208D0 (en) * 2008-09-19 2008-10-29 Pimco 2664 Ltd Therapeutic apsap compounds and their use
WO2010102154A2 (en) * 2009-03-05 2010-09-10 Ligand Pharmaceuticals Incorporated Biaryl oxyacetic acid compounds
WO2011115892A1 (en) * 2010-03-15 2011-09-22 Griffin Patrick R Modulators of the retinoic acid receptor-related orphan receptors
WO2012158784A2 (en) * 2011-05-16 2012-11-22 Theodore Mark Kamenecka Modulators of the nuclear hormone receptor ror
GB201116641D0 (en) * 2011-09-27 2011-11-09 Glaxo Group Ltd Novel compounds
US20130190356A1 (en) * 2011-12-22 2013-07-25 Genentech, Inc. Benzyl sulfonamide derivatives as rorc modulators
UY34765A (es) * 2012-04-27 2013-11-29 Glaxo Group Ltd Compuestos novedosos.

Also Published As

Publication number Publication date
HK1258966A1 (zh) 2019-11-22
MX2015006844A (es) 2015-09-16
BR112015007862A2 (pt) 2017-07-04
CN104684891A (zh) 2015-06-03
US9302985B2 (en) 2016-04-05
EP2928863A1 (en) 2015-10-14
JP2016502975A (ja) 2016-02-01
JP6367823B2 (ja) 2018-08-01
CA2886471A1 (en) 2014-06-19
WO2014090710A1 (en) 2014-06-19
CN108409613A (zh) 2018-08-17
RU2015124564A (ru) 2017-01-12
KR20150092162A (ko) 2015-08-12
US20140163110A1 (en) 2014-06-12

Similar Documents

Publication Publication Date Title
HK1244781A1 (zh) 作為rorc調節劑的芳基磺內酰胺衍生物
HK1200713A1 (en) Benzyl sulfonamide derivatives as rorc modulators rorc
HK1201526A1 (zh) 作為 調節劑的苄基磺酰胺衍生物
HK1214598A1 (zh) 作為 調節劑的苄基磺酰胺衍生物
EP2838564A4 (en) ALPHA-D-GLUCANES HIGHLY RAMIFIED
HK1210146A1 (en) Substituted sulfonamide compounds
EP2876220A4 (en) DREDGING
EP2845051A4 (en) ELECTROCHROME DEVICES
ZA201404836B (en) Benzyl sulfonamide derivatives useful as mogat-2inhibitors
HK1205508A1 (en) New bicyclicpyridine derivatives
GB2508062B (en) Sealed mirror head
GB201219116D0 (en) Optical modulator
HK1223933A1 (zh) 作為 調節劑的酮-咪唑並呲啶衍生物
EP2817589B8 (fr) Inclinomètre
PL2838883T3 (pl) Nowe pochodne fenylo-tetrahydroizochinoliny
HK1215571A1 (zh) 二鹽酸科比思特
HK1258966A1 (zh) 作為rorc調節劑的苄基磺酰胺衍生物
EP2896613A4 (en) SULFONAMIDE COMPOUND
GB2503536B (en) Hinge
EP2720530A4 (en) BOOM
EP2746847A4 (en) ELECTROCHEMICAL MIRROR
GB2506431B (en) Hinge
GB2503044B (en) Replacement mirror
AU2012904333A0 (en) Ballast Undercutter
AU2012903328A0 (en) Ballast Undercutter